Philadelphia VC firm creates obesity drug startup, raises $159.8M Series A

In The Media 8-Jan-2026

Make Weight Loss Last

With effect from 1 September 2026:
Alveus Therapeutics Inc
One Financial Center, Suite 2310
Boston, MA 02111
US

Alveus Therapeutics ApS
Palægade 4
3rd floor
1261 Copenhagen K.
Denmark
VAT number 44689790

Site by Stoere Binken